Skip to content

Released Apr 30, 2015, after the close

10-Q filed May 1, 2015, 31 days after period end · 0000917520-15-000022

Q1 2015 · 10-Q
Revenue$202.53M−5.8% vs Q1 2014−7.5% vs Q4 2014
Net Income$8.38M+280.1% vs Q1 2014−51.2% vs Q4 2014
EPS Diluted$0.13+85.7% vs Q1 2014−75.0% vs Q4 2014
Gross Profit$127,313,000+13.1%
Operating Income$21,240,000+143.1%
Operating Cash Flow$31,619,000+181.0%
Free Cash Flowderived$26,289,000N/M
Margins · derived
Gross margin62.9%+10.5 pt vs Q1 2014
Operating margin10.5%+6.4 pt vs Q1 2014
Net margin4.1%+3.1 pt vs Q1 2014

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ1 2015Q1 2014Q1 2013Q1 2012
Revenue$202.53M$215.06M$196.65M$196.19M
Net Income$8.38M$2.21M-$6.03M$6.69M
EPS Diluted$0.13$0.07-$0.22$0.23

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Integra Lifesciences Holdings Corp · CIK 917520 · Engraved from SEC EDGAR